Long-term results of a randomised trial of involved field radiotherapy vs extended field radiotherapy in stage I and II Hodgkin lymphoma

Clinical Oncology

Volumn 17, Issue 1, 2005, Pages 47-53

  Hoskin, Peter J ^a,g   Smith, P ^b   Maughan, T S ^c   Gilson, D ^d   Vernon, C ^e   Syndikus, I ^f   Linch, D C ^b  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c VELINDRE CANCER CENTRE   (United Kingdom)

^d Northern and Yorkshire Clinical Trials and Research Unit   (United Kingdom)

^e IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^f CLATTERBRIDGE HOSPITAL   (United Kingdom)

^g MOUNT VERNON CANCER CENTRE   (United Kingdom)

Author keywords

Hodgkins; Involved field; Lymphoma; Radiotherapy; Second malignancy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; INTERMETHOD COMPARISON; LONG TERM CARE; LUNG CANCER; LYMPH NODE IRRADIATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION FIELD; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGED; DOSE FRACTIONATION; FEMALE; HODGKIN DISEASE; HUMANS; LAPAROTOMY; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, RADIATION-INDUCED; RADIATION INJURIES; RECURRENCE; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 11844294144     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2004.07.004     Document Type: Article

References (26)

1. M.V. Peters A study of survivals in Hodgkin's disease treated radiologically Am J Roentgenol Radium Ther 63 1950 299-311
2. E.C. Easson M.H. Russel The cure of Hodgkin's disease Br Med J 1 1963 1704-1707
3. M. Tubiana M. Henry-Amar M. Hayat et al. The EORTC treatment of early stage Hodgkin's disease: The role of radiotherapy Int J Radiat Oncol Biol Phys 10 1984 197
4. L. Specht R.G. Gray M.J. Clarke R. Peto Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: A meta-analysis of 23 randomized trials involving 3,888 patients J Clin Oncol 16 1998 830-843
5. M.A. Tucker C.N. Coleman R.S. Cox et al. Risk of second cancers after treatment for Hodgkin's disease N Engl J Med 322 1988 76-81
6. F.E. Van Leeuwen W.J. Klokman A. Hagenbeek et al. Second cancer risk following Hodgkin's disease: A 20 year follow-up study J Clin Oncol 12 1994 312-325
7. A.J. Swerdlow J.A. Barber G. Vaughan Hudson et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment J Clin Oncol 18 2000 487-497
8. J.F. Boivin G.B. Hutchison Coronary heart disease mortality after irradiation for Hodgkin's disease Cancer 55 1982 795-802
9. M. Henry-Amar M. Hayat J.H. Meerwalst et al. Causes of death after therapy for Hodgkin's disease entered into EORTC protocols Int J Radiat Oncol Biol Phys 9 1990 1155-1157
10. S.L. Hancock M.A. Tucker R.T. Hoppe Factors affecting late mortality from heart disease after treatment of Hodgkin's disease JAMA 270 1993 1949-1955
11. B. Vaughan Hudson G. Vaughan Hudson D.C. Linch et al. Late mortality in young BNLI patients cured of Hodgkin's disease Ann Oncol 5 Suppl 2 1994 S65-S66
12. A.K. Ng M.P. Bernado E. Weller et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger J Clin Oncol 20 2002 2101-2108
13. E.L. Kaplan P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457-481
14. S.B. Sutcliffe D.E. Gospodarowicz D.E. Bergsagel et al. Prognostic groups for management of localised Hodgkin's disease J Clin Oncol 3 1985 393-401
15. S.A. Rosenberg H.S. Kaplan The evolution and summary results of the Stanford randomised trials of the management of Hodgkin's disease: 1962-1984 Int J Radiat Oncol Biol Phys 11 1985 5-22
16. G.B. Hutchison Radiotherapy of stage I and II Hodgkin's disease: A collaborative study Cancer 54 1984 1928-1942
17. S.J. Horning R.T. Hoppe S.L. Hancock S.A. Rosenberg Vinblastine, bleomycin and methotrexate: An effective adjuvant in favourable Hodgkin's disease J Clin Oncol 6 1989 1822-1831
18. A.M. Moody J. Pratt G. Vaughan Hudson et al. British national lymphoma investigation: Pilot studies of neoadjuvant chemotherapy in clinical stage Ia and IIa Hodgkin's disease Clin Oncol 13 2001 262-268
19. M.A. Harris J.A. Radford D.P. Deakin et al. Limited field radiotherapy for early stage infra-diaphragmatic Hodgkins lymphoma Clin Oncol 16 2004 53-57
20. R.H. Advani S.J. Horning Treatment of early-stage Hodgkin's disease Semin Hematol 36 1999 270-281
21. L. Yung D.C. Linch Hodgkin's Lymphoma Lancet 361 2003 945-951
22. E.M. Noordijk P. Carde A. Hagenbeek et al. Combination of radiotherapy and chemotherapy is advisable in all patients with clinical stage I-II HD. Six year results of the EORTC - GPMC controlled clinical trials H7 - VF, H7 - F, H7 - U Int J Radiat Oncol Biol Phys 1997 39
23. F.E. Van Leeuwen W.J. Klokman M. Stovall et al. Roles of radiation dose, chemotherapy and hormonal factors in breast cancer following Hodgkins disease J Natl Cancer Inst 95 2003 971-980
24. P.M. Maunch L.A. Kaliah K.C. Marcus et al. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: Long term analysis of risk factors and outcome Blood 9 1996 3625-3632
25. L.B. Travis M. Gospodarowicz R.E. Curtis et al. Lung cancer following chemotherapy and radiotherapy for Hodgkins disease J Natl Cancer Inst 94 2002 182-192
26. S. Bhatia L.L. Robison O. Oberlin et al. Breast cancer and other second neoplasms after childhood Hodgkins disease N Engl J Med 334 1996 745-751